These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12898374)

  • 1. Leptin, soluble leptin receptor, and transforming growth factor-beta1 levels in minimal change nephrotic syndrome.
    Buyan N; Ozkaya O; Bideci A; Söylemezoğlu O; Cinaz P; Gönen S; Kalman S; Bakkaloğlu S; Hasanoğlu E
    Pediatr Nephrol; 2003 Oct; 18(10):1009-14. PubMed ID: 12898374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased soluble leptin receptor in children with nephrotic syndrome.
    Schroth M; Kratzsch J; Gröschl M; Rauh M; Rascher W; Dötsch J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5497-501. PubMed ID: 14602796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence.
    Kratzsch J; Lammert A; Bottner A; Seidel B; Mueller G; Thiery J; Hebebrand J; Kiess W
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4587-94. PubMed ID: 12364439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity.
    Misra M; Miller KK; Almazan C; Ramaswamy K; Aggarwal A; Herzog DB; Neubauer G; Breu J; Klibanski A
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3486-95. PubMed ID: 15240636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition.
    Pecoits-Filho R; Nordfors L; Heimbürger O; Lindholm B; Anderstam B; Marchlewska A; Stenvinkel P
    Eur J Clin Invest; 2002 Nov; 32(11):811-7. PubMed ID: 12423321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population.
    Ogawa T; Hirose H; Yamamoto Y; Nishikai K; Miyashita K; Nakamura H; Saito I; Saruta T
    Metabolism; 2004 Jul; 53(7):879-85. PubMed ID: 15254881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
    Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
    Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin.
    Porreca E; Di Febbo C; Vitacolonna E; Baccante G; Di Castelnuovo A; Angelini A; Febo F; Di Nisio M; Cuccurullo F
    Am J Hypertens; 2002 Sep; 15(9):759-65. PubMed ID: 12219869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Wierciński R; Winiecka W; Smółko M; Porowski T; Koput A; Janicka K
    Pol Merkur Lekarski; 2003 Aug; 15(86):172-5. PubMed ID: 14648986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor.
    Kratzsch J; Knerr I; Galler A; Kapellen T; Raile K; Körner A; Thiery J; Dötsch J; Kiess W
    Eur J Endocrinol; 2006 Oct; 155(4):609-14. PubMed ID: 16990661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens.
    Sepilian VP; Crochet JR; Nagamani M
    Fertil Steril; 2006 May; 85(5):1441-7. PubMed ID: 16579998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased soluble leptin receptor levels in women with polycystic ovary syndrome.
    Hahn S; Haselhorst U; Quadbeck B; Tan S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2006 Feb; 154(2):287-94. PubMed ID: 16452543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
    Park HC; Xu ZG; Choi S; Goo YS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.
    Yannakoulia M; Yiannakouris N; Blüher S; Matalas AL; Klimis-Zacas D; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1730-6. PubMed ID: 12679465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum soluble leptin receptor levels in children and adolescents with type 1 diabetes mellitus.
    Kratzsch J; Deimel A; Galler A; Kapellen T; Klinghammer A; Kiess W
    Eur J Endocrinol; 2004 Oct; 151(4):475-81. PubMed ID: 15476448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A twin study for serum leptin, soluble leptin receptor, and free insulin-like growth factor-I in pubertal females.
    Li HJ; Ji CY; Wang W; Hu YH
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3659-64. PubMed ID: 15784711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data.
    Zastrow O; Seidel B; Kiess W; Thiery J; Keller E; Böttner A; Kratzsch J
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1472-8. PubMed ID: 14634677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors.
    Wasilewska AM; Zoch-Zwierz WM
    Pediatr Nephrol; 2004 Dec; 19(12):1349-53. PubMed ID: 15490252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin.
    Laimer M; Ebenbichler CF; Kaser S; Sandhofer A; Weiss H; Nehoda H; Aigner F; Patsch JR
    Obes Res; 2002 Jul; 10(7):597-601. PubMed ID: 12105280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.